肝硬化腹水合并肝性胸水的早期临床预防  

作　　者：张弦[1] 陈卫星[1] 杨云梅[1] 

机构地区：[1]浙江大学医学院附属第一医院干部病房,310003

出　　处：《浙江临床医学》2009年第8期813-815,共3页Zhejiang Clinical Medical Journal

摘　　要：目的探讨肝硬化腹水合并肝性胸水的早期预防。方法对2004年1月到2008年12月入住本院的肝硬化腹水患者中合并肝性胸水者的临床资料进行回顾性分析。结果共366例肝硬化腹水患者中，58例合并肝性胸水，经综合治疗后52例明显好转，其中42例基本吸收，6例无明显变化（5例死亡）。结论肝硬化腹水合并肝性胸水多见于终末期肝硬化患者，常提示病情的严重性，且胸水量的多少与病情严重程度密切相关，尤其是大量积液者，常并发出血、感染等严重并发症，预后很差。早期预防及治疗对胸水转归及疾病预后有着重要的意义。Objective To study the early prevention of hepatic hydrothorax. Methods A retrospective study was made on 366 patients diagnosed of ascites due to cirrhosis with hepatic hydrothorax from January, 2004 to December, 2008 in our hospital. Results In the total of 366 patients, there were 58 who had hepatic hydrothorax. All of them were given combined treatment. 52 patients got better, among them, 42 patients had complete regression,6 patients had no change and 5 died. Conclusions Hepatic hydrothorax is always seen in final stage of hepatic cirrhosis and is the sign of poor prognosis. In addition, the amount of effusions is always related to the progression of the diseas, patients with large mount of effusion are often complicated with bleeding, infection and other severe complications. So that early prevention and therapy to hepatic hydrothorax is very important for the prognosis of the disease.

关 键 词：肝硬化 腹水 肝性胸水 预防 

分 类 号：R259.752[医药卫生—中西医结合] R561.3[医药卫生—中医内科学]